China (Wuxi) University Tech Park of Sensing Network

Allogene Overland Biopharm Appoints Shuyuan Yao as Chief Executive Officer

Retrieved on: 
Monday, June 21, 2021
Research, Genetics, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, Other Science, WuXi AppTec, China (Wuxi) University Tech Park of Sensing Network, Wuxi, East China, Life sciences, Cities in China, Allogene Overland Biopharm, Overland Pharmaceuticals, Allogene Therapeutics, ALLOGENE OVERLAND BIOPHARM, OVERLAND PHARMACEUTICALS, ALLOGENE THERAPEUTICS

Allogene Overland Biopharm (Allogene Overland), a joint venture created by Overland Pharmaceuticals and Allogene Therapeutics, Inc. (Nasdaq: ALLO), today announced the appointment of Shuyuan Yao, Ph.D. as Chief Executive Officer.

Key Points: 
  • Allogene Overland Biopharm (Allogene Overland), a joint venture created by Overland Pharmaceuticals and Allogene Therapeutics, Inc. (Nasdaq: ALLO), today announced the appointment of Shuyuan Yao, Ph.D. as Chief Executive Officer.
  • Most recently, Dr. Yao served as Chief Scientific Officer, Head of Research & Technology Development of WuXi Advanced Therapies at WuXi AppTec where he led new technology acquisition, development, translation and application.
  • Prior to being CSO, Dr. Yao served as WuXi Advanced Therapies China General Manager, establishing a new subsidiary company, ATU China.
  • Shuyuan has deep experience in drug development, commercialization and joint venture building, particularly in cell therapy, said David Chang, M.D., Ph.D., President, Chief Executive Officer and Co-Founder of Allogene.

Borqs Technologies Signs Strategic MOU for 5G Industrial Park Project in South Taihu New Area of Zhejiang Province, China

Retrieved on: 
Monday, November 23, 2020
East China, Cities in China, Huzhou, 5G, Lake Tai, Telecommunications, China (Wuxi) University Tech Park of Sensing Network, FAW Bus and Coach

The company intends to setup a Joint Venture in South Taihu New Area in the near term which will serve as Borqs China headquarters for 5G activities, including sales, R&D center, and manufacturing.

Key Points: 
  • The company intends to setup a Joint Venture in South Taihu New Area in the near term which will serve as Borqs China headquarters for 5G activities, including sales, R&D center, and manufacturing.
  • First, a 5G R&D center and up to 10 micro-electronics manufacturing lines will be established.
  • The Joint Venture will be provided rent-free facilities of 5,500 square meters for two and a half years.
  • About Huzhou South Taihu New Area of Zhejiang province, China
    The South Taihu New Area of Huzhou City was officially established on June 2, 2019, and is one of the four new areas established by the provincial government.

Glory Star Establishes Digital Economy Headquarters in Wuxi and Partners with Wuxi Municipal Government to Build New Economic and Cultural Industrial Park

Retrieved on: 
Monday, October 19, 2020
Jiangnan, Wuxi, Yangtze River Delta, Geography of China, East China, Jiangsu, Binhu District, China (Wuxi) University Tech Park of Sensing Network

The Company held a signing ceremony on October 15, 2020, to commemorate the start of the Park project and development.

Key Points: 
  • The Company held a signing ceremony on October 15, 2020, to commemorate the start of the Park project and development.
  • Glory Star plans to focus on four areas during the development of the park, including new media, new retail, technology, and the Companys internal vocational program Cheers Academy.
  • Xin Huang, Secretary of the Wuxi Municipal Committee, commented on behalf of the Wuxi Municipal Government, The successful cooperation between the Wuxi Municipal Government and Glory Star has ushered in a new and important driver for Chinas digital content industry.
  • Mr. Bing Zhang, Founder and Chief Executive Officer of Glory Star, commented, With the support and assistance of the Wuxi Municipal Government, Binhu District Government, and other relevant government departments, we have established our digital economy headquarters, which we consider to be our most important business headquarters, in Wuxi.

Wuxi opens its arms to global talents, 2020 Taihu Talent Summit is held in Wuxi

Retrieved on: 
Friday, August 7, 2020
Yangtze River Delta, Cities in China, East China, Geography of China, Wuxi, Jiangnan, China (Wuxi) University Tech Park of Sensing Network, Suzhou, Jiangsu, Nanjing, Jiangnan University, FAW Bus and Coach

NANJING, China, Aug. 7, 2020 /PRNewswire/ -- On August 5, the 2020 Taihu Talent Summit officially started in Wuxi, Jiangsu, China.

Key Points: 
  • NANJING, China, Aug. 7, 2020 /PRNewswire/ -- On August 5, the 2020 Taihu Talent Summit officially started in Wuxi, Jiangsu, China.
  • With the theme of "New Era, New Talent, New Ecology", Wuxi, this Jiangnan ancient city, opened its arms to global talents.
  • This summit is supported by many international and domestic institutions and associations.
  • 20 Chinese and foreign academicians, more than 700 experts from colleges and universities, Top 500 companies, science and technology companies, and media institutions got together with talent representatives and sought common development, according to the organizing committee of Taihu Talent Summit 2020.

Wuxi opens its arms to global talents, 2020 Taihu Talent Summit is held in Wuxi

Retrieved on: 
Friday, August 7, 2020
Yangtze River Delta, Cities in China, East China, Geography of China, Wuxi, Jiangnan, China (Wuxi) University Tech Park of Sensing Network, Suzhou, Jiangsu, Nanjing, Jiangnan University, FAW Bus and Coach

NANJING, China, Aug. 7, 2020 /PRNewswire/ -- On August 5, the 2020 Taihu Talent Summit officially started in Wuxi, Jiangsu, China.

Key Points: 
  • NANJING, China, Aug. 7, 2020 /PRNewswire/ -- On August 5, the 2020 Taihu Talent Summit officially started in Wuxi, Jiangsu, China.
  • With the theme of "New Era, New Talent, New Ecology", Wuxi, this Jiangnan ancient city, opened its arms to global talents.
  • This summit is supported by many international and domestic institutions and associations.
  • 20 Chinese and foreign academicians, more than 700 experts from colleges and universities, Top 500 companies, science and technology companies, and media institutions got together with talent representatives and sought common development, according to the organizing committee of Taihu Talent Summit 2020.

WuXi NextCODE and Olink Proteomics announce strategic cooperation

Retrieved on: 
Wednesday, July 8, 2020
Wuxi, Academic journals, Proteomics, Omics, Omics, Genomics, China (Wuxi) University Tech Park of Sensing Network, Publications, East China

UPPSALA, Sweden and SHANGHAI, July 8, 2020 /PRNewswire/ -- WuXi NextCODE Genomics Co., Ltd. ("WuXi NextCODE") and Olink Proteomics AB today announced a strategic cooperation in China which gives WuXi NextCODE exclusivity as third-party provider of services using Olink products to customers in mainland China.

Key Points: 
  • UPPSALA, Sweden and SHANGHAI, July 8, 2020 /PRNewswire/ -- WuXi NextCODE Genomics Co., Ltd. ("WuXi NextCODE") and Olink Proteomics AB today announced a strategic cooperation in China which gives WuXi NextCODE exclusivity as third-party provider of services using Olink products to customers in mainland China.
  • It will also mean that WuXi NextCODE will further improve their capability for high-throughput multi-omics research, based on genomics, transcriptomics and proteomics.
  • Lele Sun, Ph.D. General Manager of WuXi NextCODE said, "We are pleased to become the strategic partner of Olink on the China market to promote Olink technology for detection of actionable protein biomarkers.
  • With that, WuXi NextCODE enters into a new era of providing multi-omics services to its customers, combining its genomics capability with Olink proteomics technology, to serve customers with comprehensive solutions for precision medicine."

WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility

Retrieved on: 
Friday, January 3, 2020
Life sciences, WuXi AppTec, Biology, Articles, Wuxi, Biotechnology, China (Wuxi) University Tech Park of Sensing Network, Morpholino, WuXi Biologics

SHANGHAI, Jan. 2, 2020 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) a subsidiary of WuXi AppTec today announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China.

Key Points: 
  • SHANGHAI, Jan. 2, 2020 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) a subsidiary of WuXi AppTec today announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China.
  • WuXi STA's comprehensiveplatform covers the development and manufacturing of a variety of oligonucleotide modalities including DNA, RNA, Morpholino oligonucleotide (PMO) and peptide conjugates (PPMO).
  • The opening of this large scale manufacturing facility will empower more global partners to expedite the development and commercialization of oligonucleotide drugs to benefit patients worldwide," commented Dr. Minzhang Chen, CEO of WuXi STA.
  • STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life sciences industry, with operations in China and the United States.

WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing

Retrieved on: 
Friday, June 21, 2019
Life sciences, Articles, Pharmaceutical industry, Wuxi, Biotechnology, Biopharmaceutical, Pharmacy, Biocon, China (Wuxi) University Tech Park of Sensing Network, WuXi AppTec

WUXI, China, June 20, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it planned to expand the new state-of-the-art integrated biologics conjugation solution center to include commercial manufacturing in Wuxi city, China.

Key Points: 
  • WUXI, China, June 20, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it planned to expand the new state-of-the-art integrated biologics conjugation solution center to include commercial manufacturing in Wuxi city, China.
  • Last June, WuXi Biologics announced the building of an integrated biologics conjugation solution center, including process development and clinical manufacturing for ADCs drug substance and drug product.
  • "We are quite excited to expand construction of this new integrated biologics conjugation solution center, which will further enhance our technical capabilities and manufacturing capacities in the fast-growing bioconjugation field," said Dr. Chris Chen, CEO of WuXi Biologics.
  • WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing.